| Announce Date | 11/05/2025 |
| EPS Normalized Actual | $1.32 (Beat by $0.03) |
| EPS GAAP Actual | $1.32 (Beat by $0.03) |
| Revenue Actual | $1.75409B |
| Revenue Surprise | Beat by $1754.09M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 0 | INF | 0 | 0 | 1 |
| Dec 2028 | 0 | INF | 0 | 0 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.28 | 0.28 | 1.75409B | 11.22% | 1754.09M |
| FQ2 2025 (Jun 2025) | -0.15 | -0.15 | 1.71195B | 10.37% | 1711.95M |
| FQ1 2025 (Mar 2025) | 0.05 | 0.05 | 1.59253B | 7.26% | 1592.53M |
| FQ4 2024 (Dec 2024) | 0.35 | 0.35 | 1.58128B | 10.21% | 1581.28M |
| FQ3 2024 (Sep 2024) | -0.11 | -0.11 | 1.55736B | 10.86% | 1557.36M |
| FQ2 2024 (Jun 2024) | 0.12 | 0.12 | 1.53441B | 11.5% | 1534.41M |
| FQ1 2024 (Mar 2024) | 0.25 | 0.25 | 1.47686B | 11% | 1476.86M |
| FQ4 2023 (Dec 2023) | 0 | 0 | 1.41983B | 9.92% | 1419.83M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.56247 | -- | 0.53395 | 0.57963 | 1 |
| FQ3 2027 (Sep 2027) | 0.52345 | -- | 0.49691 | 0.53942 | 1 |
| FQ2 2027 (Jun 2027) | 0.49242 | -- | 0.46745 | 0.50744 | 1 |
| FQ1 2027 (Mar 2027) | 0.47288 | -- | 0.4489 | 0.4873 | 1 |
| FQ4 2026 (Oct 2026) | 0.57023 | -- | 0.55973 | 0.58098 | 1 |
| FQ3 2026 (Jul 2026) | 0.4496 | 37.72 | 0.44132 | 0.45807 | 1 |
| FQ2 2026 (Jun 2026) | 0.54408 | 127.57 | 0.51649 | 0.56067 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 2.06B | -- | 1.98B | 2.11B | 2 |
| FQ3 2027 (Sep 2027) | 2.01B | -- | 1.93B | 2.05B | 2 |
| FQ2 2027 (Jun 2027) | 1.95B | -- | 1.87B | 1.99B | 2 |
| FQ1 2027 (Mar 2027) | 1.83B | -- | 1.76B | 1.87B | 2 |
| FQ4 2026 (Oct 2026) | 1.76B | -- | 1.74B | 1.79B | 2 |
| FQ3 2026 (Jul 2026) | 1.71B | -2.67 | 1.68B | 1.73B | 2 |
| FQ2 2026 (Jun 2026) | 1.89B | 9.28 | 1.81B | 1.93B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
2
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.28 | 0.28 | 100% | |
| FQ2 2025 (Jun 2025) | -0.15 | -0.15 | 100% | |
| FQ1 2025 (Mar 2025) | 0.05 | 0.05 | 100% | |
| FQ4 2024 (Dec 2024) | 0.35 | 0.35 | 100% | |
| FQ3 2024 (Sep 2024) | -0.11 | -0.11 | 100% | |
| FQ2 2024 (Jun 2024) | 0.12 | 0.12 | 100% | |
| FQ1 2024 (Mar 2024) | 0.25 | 0.25 | 100% | |
| FQ4 2023 (Dec 2023) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $1.75B | $1754.09M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $1.71B | $1711.95M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $1.59B | $1592.53M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.58B | $1581.28M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.56B | $1557.36M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.53B | $1534.41M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.48B | $1476.86M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $1.42B | $1419.83M | 100% |